Press Releases

For a full overview of our announcements and press releases, visit our Euronext Oslo Børs Newsweb

NewsWeb

Newest first
Oldest first

15/04/2025

Nykode Announces that Michael Engsig, CEO; Agnete Fredriksen, CSO & Co-founder; and Harald Gurvin, CFO; have withdrawn their recent resignations and continue with Nykode; proposal of new Board members; potential dividend of NOK 1.00 per share

02/04/2025

Nykode Therapeutics ASA – Notice of Extraordinary General Meeting

27/03/2025

Nykode Therapeutics – resignation of Chair of the Board, Board Members, Chief Executive Officer, Chief Scientific Officer and Chief Financial Officer

27/02/2025

Nykode Therapeutics Announces Preclinical Data Highlighting its Immune Tolerance Platform’s Ability to Modulate Multiple Key Immune Components in Autoimmune Disease

26/02/2025

Nykode Therapeutics reports Q4 2024 Financial Results

Pages: 12345678910111213141516171819202122232425262728293031323334353637383940